FDA Guidance for Industry: Biological Product Deviation Reporting for Blood and Plasma Establishments

Titel:
FDA Guidance for Industry: Biological Product Deviation Reporting for Blood and Plasma Establishments
Herkunft/Verlag:

Freedom of Information Staff, (HFI 35), Food and Drug Administration, Rm. 12 A - 30, 5600 Fishers Lane, Rockville, MD 20857, USA, http://www.fda.gov/ , http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM062918.pdf

Dokumentenart:
Guidance for Industry
Inhalt:
Leitfaden zur Vorgehensweise bei der Meldung von Abeichungen im Rahmen des BPD Berichts

Zurück

GMP Seminare nach Thema